GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript

Page 4 of 4

Katherine Stueland : Yes. So starting with EMR, I would say, it’s something that we do routinely, and we will continue to focus on that to open up access. So I put that in as kind of table stakes in terms of how we operate, how we make it easier to work with us, how we continue to smooth out the customer experience. So that is something that we’ll continue to invest in because it honestly pays for itself. And in terms of test retirement, we’re really pleased, as I mentioned earlier, that we were able to retire the 350 or so tests. And we feel like we have a healthy test menu and a very focused sales team and operations team that’s going to continue to drive the conversion to exome and genome. And as we keep making progress with that, we’ll continue to, I think, have a healthy approach to reviewing that test menu to retiring tests over time.

We want to make sure that we can continue on the steady growth rate, we feel like we’re in a position of strength in terms of the overall commercial strategy. And how that links up to our operations team, there’s a really beautiful handoff that we’re seeing between those two teams that keeps everyone really focused on near-term execution. So we feel like we’re in a great place in terms of getting volume in the door, get it reports out and continuing to get good volume, continue to focus on that account profitability and drive us forward towards profitability in 2025.

Vidyun Bais: Excellent. Thanks for taking the questions.

Operator: Thank you. This does conclude the question-and-answer session of today’s program. I’d like to hand the program back to Katherine Stueland for any further remarks.

Katherine Stueland: Awesome. Thank you so much, Jonathan, and thank you to everyone for joining us. We’re excited about 2024, and we’ll be at upcoming conferences in the coming weeks and look forward to seeing you all then. Thanks so much.

Operator: Thank you, ladies and gentlemen, for your participation in today’s conference. This does conclude the program. You may now disconnect. Good day.

Follow Genedx Holdings Corp.

Page 4 of 4